Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: A double-blind, placebo-controlled, randomised, repeated cross-over study

摘要

1 This study evaluated 1 year the efficacy of therapy with nicardipine in patients with chronic stable angina pectoris. Twenty-five male patients were entered. After a placebo run-in phase, the patients received nicardipine 30 mg, nicardipine 40 mg, and placebo, three times daily given in random, double-blind manner for 8 weeks.